-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, TweEzCmNSgDl8cqcqrrlOf0seNvxNBQEflZdktgSNyWiolL0amXmmAiTFbKPdTAZ VfVX/96ke/cxCYe72TitMQ== 0001140361-10-047771.txt : 20101202 0001140361-10-047771.hdr.sgml : 20101202 20101202150458 ACCESSION NUMBER: 0001140361-10-047771 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20101130 FILED AS OF DATE: 20101202 DATE AS OF CHANGE: 20101202 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Obagi Medical Products, Inc. CENTRAL INDEX KEY: 0001375247 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 954658730 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3760 KILROY AIRPORT WAY STREET 2: #500 CITY: LONG BEACH STATE: CA ZIP: 90806 BUSINESS PHONE: 562-628-1007 MAIL ADDRESS: STREET 1: 3760 KILROY AIRPORT WAY STREET 2: #500 CITY: LONG BEACH STATE: CA ZIP: 90806 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: STONINGTON CAPITAL APPRECIATION 1994 FUND L P CENTRAL INDEX KEY: 0001047028 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33204 FILM NUMBER: 101227612 BUSINESS ADDRESS: STREET 1: 767 FIFTH AVENUE CITY: NEW YORK STATE: NY ZIP: 10153 BUSINESS PHONE: 2123398536 MAIL ADDRESS: STREET 1: 767 FIFTH AVE CITY: NEW YORK STATE: NY ZIP: 10153 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: STONINGTON PARTNERS INC II CENTRAL INDEX KEY: 0001047030 STATE OF INCORPORATION: DE FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33204 FILM NUMBER: 101227611 BUSINESS ADDRESS: STREET 1: 767 FIFTH AVENUE CITY: NEW YORK STATE: NY ZIP: 10153 BUSINESS PHONE: 2123398536 MAIL ADDRESS: STREET 1: 767 FIFTH AVE CITY: NEW YORK STATE: NY ZIP: 10153 4 1 doc1.xml FORM 4 X0303 4 2010-11-30 1 0001375247 Obagi Medical Products, Inc. OMPI 0001047028 STONINGTON CAPITAL APPRECIATION 1994 FUND L P 600 MADISON AVENUE NEW YORK NY 10022 0 0 1 0 0001047030 STONINGTON PARTNERS INC II 600 MADISON AVE. NEW YORK NY 10022 0 0 1 0 Common Stock 2010-11-30 4 S 0 2688668 9.84 D 0 D The record holder of such shares is Stonington Capital Appreciation 1994 Fund, L.P. (the "Stonington Fund").The Stonington Fund is a Delaware limited partnership whose limited partners consist of certain institutional investors, formed to invest in corporate acquisitions organized by Stonington Partners, Inc. Stonington Partners, L.P., a Delaware limited partnership, is the general partner in the Stonington Fund with a 1% economic interest. Except for such economic interest, Stonington Partners, L.P. disclaims beneficial ownership of the shares set forth above. Stonington Partners, Inc. II is the general partner of, with a 1% interest in, Stonington Partners, L.P. Except for such economic interest, Stonington Partners, Inc. II disclaims beneficial ownership of the shares set forth above. Pursuant to a management agreement with the Stonington Fund, Stonington Partners, Inc. has full discretionary authority with respect to the investments of the Stonington Fund, including th e authority t The Stonington Fund sold such shares to Obagi Medical Products, Inc. (the "Company") in accordance with the terms of a Stock Purchase Agreement, dated as of November 15, 2010, by and among the Company, the Stonington Fund and the other selling stockholder signatory thereto. Such total also reflects the sale by the Stonington Fund of 2,033,617 shares of the Company's common stock in November 2010 pursuant to a registration statement on Form S-1 that was filed with the Securities and Exchange Commission (the "SEC") on October 26, 2010 and declared effective by the SEC on November 15, 2010. Such sale was exempt from the reporting requirements of Section 16(a) under the Securities Exchange Act of 1934, as amended, pursuant to Rule 16a-7 promulgated thereunder. John A. Bartholdson 2010-12-02 John A. Bartholdson 2010-12-02 -----END PRIVACY-ENHANCED MESSAGE-----